Your search returned 37 studies. (Get alerts for new studies):
- Phase I & II Trial of Intravesicular Abraxane for Treatment-refractory Bladder Cancer
Conditions: Bladder Cancer
1 Location available
- Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer
Conditions: Superficial Bladder Cancer
1 Location available
- Molecular Analysis Of Bladder Cancer
Conditions: Bladder Cancer - Bladder Neoplasms
1 Location available
- Evaluation of Non-Invasive Assay(s) for the Detection of Bladder Cancer
Conditions: Bladder Cancer - Cancer - Bladder Neoplasms - Urinary Bladder Cancer
1 Location available
- A Study of Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile Ducts
Conditions: Cholangiocarcinoma
3 Locations available
- PII of SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation
Conditions: Cholangiocarcinoma - Hepatobiliary Neoplasm - Liver Cancer - Bile Duct Cancer - Cancer of Gallbladder
1 Location available
- Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-Naive Patients With Advanced/Metastatic Bladder Carcinoma
Conditions: Bladder Cancer
1 Location available
- Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer
Conditions: Extrahepatic Bile Duct Cancer - Gallbladder Cancer - Gastric Cancer - Lung Cancer - Melanoma - Non-Hodgkin's Lymphoma - Uterine Cancer - CORPUS UTERI,ENDOMETRIUM - LUNG - OVARY
1 Location available
- Use of Multiphoton Microscopy in the Diagnosis of Cancer
Conditions: Bladder Cancer - Prostate Cancer
1 Location available
- Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer
Conditions: Bladder Cancer - Extrahepatic Bile Duct Cancer - Gallbladder Cancer - Liver Cancer - Lung Cancer - Pancreatic Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter
5 Locations available
- Storage of Bile From Routine Procedures to Study Risk Factors
Conditions: Gallbladder Cancer - Cholangiocarcinoma - Biliary Tract Cancer
1 Location available
- Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder
Conditions: Recurrent Bladder Cancer - Stage III Bladder Cancer - Stage IV Bladder Cancer - Transitional Cell Carcinoma of the Bladder
1 Location available
- Safety Study of MGA271 in Refractory Cancer
Conditions: Prostate Cancer - Pancreatic Cancer - Melanoma - Renal Cell Carcinoma - Ovarian Cancer - Colorectal Cancer - Gastric Cancer - Bladder Cancer - Non-small Cell Lung Cancer - Glioblastoma
2 Locations available
- Study of Individuals and Families at High Risk for Cancer
Conditions: Bladder Cancer - Brain and Central Nervous System Tumors - Chordoma - Lung Cancer - Non-melanomatous Skin Cancer - Retinoblastoma - Sarcoma
2 Locations available
- Trial of Adjuvant Sutent for Patients With High Risk Urothelial Carcinoma After Neoadjuvant Chemotherapy and Cystectomy
Conditions: Urothelial Carcinoma - Bladder Cancer
1 Location available
- RAD001 and Intravesical Gemcitabine in BCG-Refractory Primary or Secondary Carcinoma In Situ of the Bladder
Conditions: Bladder Cancer
1 Location available
- Trial of Amrubicin as Second-Line Therapy in Patients With Advanced/Metastatic Refractory Urothelial Carcinoma
Conditions: Bladder Cancer
1 Location available
- Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) on Patients at Risk of Urothelial Tumors
Conditions: Bladder Cancer
1 Location available
- Capecitabine, Gemcitabine, and Radiation Therapy in Treating Patients With Cholangiocarcinoma of the Gallbladder or Bile Duct
Conditions: Extrahepatic Bile Duct Cancer - Gallbladder Cancer
261 Locations available
- Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer
Conditions: Bladder Cancer
1 Location available
- Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium
Conditions: Bladder Cancer
1 Location available
- Broccoli Sprout Extract in Treating Patients With Transitional Cell Bladder Cancer Undergoing Surgery
Conditions: Recurrent Bladder Cancer - Stage 0 Bladder Cancer - Stage I Bladder Cancer - Stage II Bladder Cancer - Transitional Cell Carcinoma of the Bladder
1 Location available
- Adjuvant Proton Therapy or IMRT for the Treatment of Bladder Cancer
Conditions: Urothelial Carcinoma of the Bladder
1 Location available
- E7389 in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction
Conditions: Bladder Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
24 Locations available
- Cognitive and Behavioral Therapy or Standard Care in Patients With Advanced Gastrointestinal Cancer or Lung Cancer
Conditions: Anxiety Disorder - Colorectal Cancer - Depression - Esophageal Cancer - Extrahepatic Bile Duct Cancer - Gallbladder Cancer - Gastric Cancer - Liver Cancer - Lung Cancer - Pancreatic Cancer - Psychosocial Effects of Cancer and Its Treatment
1 Location available
- Quality of Life in Patients With Bladder Cancer
Conditions: Bladder Cancer
1 Location available
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer - Prostate Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
496 Locations available
- Dose Dense MVAC for Muscle Invasive Bladder Cancer
Conditions: Muscle Invasive Bladder Cancer - High Risk Urothelial Carcinoma of the Upper Urinary Tracts
2 Locations available
- A Phase I Study of MGAH22 in Patients With Refractory HER2 Positive Cancers
Conditions: Non-Small Cell Lung Neoplasms - Prostate Neoplasms - Bladder Neoplasms - Ovarian Neoplasms - Breast Neoplasms
1 Location available
- Oral Lenalidomide and Intravesical BCG for Therapy of Bladder Cancer
Conditions: Bladder Cancer
1 Location available
- A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer
Conditions: Cholangiocarcinoma - Biliary Tract Cancer - Gallbladder Cancer
1 Location available
- Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients
Conditions: Bladder Cancer
1 Location available
- Safety Study of MGAH22 in HER2-positive Carcinomas
Conditions: Breast Cancer - Gastric Cancer - Bladder Cancer - Ovarian Cancer - Non-small Cell Lung Cancer
2 Locations available
- Phase IB Intravesical Administration of SCH 721015
Conditions: Bladder Cancer
1 Location available
- Study of BCG + Aminophylline Toxicity When Used in the Treatment of Bladder Cancer
Conditions: Bladder Cancer
1 Location available
- Study of ACE-011 to Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small
Conditions: Anemia - Carcinoma, Non-Small-Cell Lung - Carcinoma, Small-Cell Lung - Bladder Cancer - Cancer of Head and Neck - Uterine Cervical Cancer
39 Locations available
- A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Conditions: Transitional Cell Carcinoma of Bladder - Urethra Cancer - Ureter Cancer - Malignant Tumor of Renal Pelvis
6 Locations available
|